186 related articles for article (PubMed ID: 14739216)
1. Hepatic low-density lipoprotein receptor-related protein deficiency in mice increases atherosclerosis independent of plasma cholesterol.
Espirito Santo SM; Pires NM; Boesten LS; Gerritsen G; Bovenschen N; van Dijk KW; Jukema JW; Princen HM; Bensadoun A; Li WP; Herz J; Havekes LM; van Vlijmen BJ
Blood; 2004 May; 103(10):3777-82. PubMed ID: 14739216
[TBL] [Abstract][Full Text] [Related]
2. An extrahepatic receptor-associated protein-sensitive mechanism is involved in the metabolism of triglyceride-rich lipoproteins.
van Vlijmen BJ; Rohlmann A; Page ST; Bensadoun A; Bos IS; van Berkel TJ; Havekes LM; Herz J
J Biol Chem; 1999 Dec; 274(49):35219-26. PubMed ID: 10575007
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency.
Bovenschen N; Herz J; Grimbergen JM; Lenting PJ; Havekes LM; Mertens K; van Vlijmen BJ
Blood; 2003 May; 101(10):3933-9. PubMed ID: 12522008
[TBL] [Abstract][Full Text] [Related]
4. Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice.
Hu L; Boesten LS; May P; Herz J; Bovenschen N; Huisman MV; Berbée JF; Havekes LM; van Vlijmen BJ; Tamsma JT
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2710-5. PubMed ID: 17038633
[TBL] [Abstract][Full Text] [Related]
5. Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice.
Furbee JW; Sawyer JK; Parks JS
J Biol Chem; 2002 Feb; 277(5):3511-9. PubMed ID: 11719520
[TBL] [Abstract][Full Text] [Related]
6. Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice.
Kawashiri M; Zhang Y; Usher D; Reilly M; Puré E; Rader DJ
J Lipid Res; 2001 Jun; 42(6):943-50. PubMed ID: 11369802
[TBL] [Abstract][Full Text] [Related]
7. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
Zsigmond E; Kobayashi K; Tzung KW; Li L; Fuke Y; Chan L
Hum Gene Ther; 1997 Nov; 8(16):1921-33. PubMed ID: 9382958
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of low density lipoprotein receptor eliminates apolipoprotein B100-containing lipoproteins from circulation and markedly prevents early atherogenesis in apolipoprotein E-deficient mice.
Murayama T; Yokode M; Horiuchi H; Yoshida H; Sano H; Kita T
Atherosclerosis; 2000 Dec; 153(2):295-302. PubMed ID: 11164418
[TBL] [Abstract][Full Text] [Related]
10. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.
Yoshikawa T; Shimano H; Chen Z; Ishibashi S; Yamada N
Horm Metab Res; 2001 Aug; 33(8):472-9. PubMed ID: 11544561
[TBL] [Abstract][Full Text] [Related]
11. Analysis of expression of genes involved in apolipoprotein E-based lipoprotein metabolism in pregnant mice deficient in the receptor-associated protein, the low density lipoprotein receptor, or apolipoprotein E.
Umans L; Overbergh L; Serneels L; Tesseur I; Van Leuven F
Biol Reprod; 1999 Nov; 61(5):1216-25. PubMed ID: 10529267
[TBL] [Abstract][Full Text] [Related]
12. Essential role for the (hepatic) LDL receptor in macrophage apolipoprotein E-induced reduction in serum cholesterol levels and atherosclerosis.
Van Eck M; Van Dijk KW; Herijgers N; Hofker MH; Groot PH; Van Berkel TJ
Atherosclerosis; 2001 Jan; 154(1):103-12. PubMed ID: 11137088
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
Véniant MM; Withycombe S; Young SG
Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1567-70. PubMed ID: 11597927
[TBL] [Abstract][Full Text] [Related]
14. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins.
Ishibashi S; Herz J; Maeda N; Goldstein JL; Brown MS
Proc Natl Acad Sci U S A; 1994 May; 91(10):4431-5. PubMed ID: 8183926
[TBL] [Abstract][Full Text] [Related]
15. Effect of an oral astaxanthin prodrug (CDX-085) on lipoprotein levels and progression of atherosclerosis in LDLR(-/-) and ApoE(-/-) mice.
Ryu SK; King TJ; Fujioka K; Pattison J; Pashkow FJ; Tsimikas S
Atherosclerosis; 2012 May; 222(1):99-105. PubMed ID: 22406426
[TBL] [Abstract][Full Text] [Related]
16. Human PCSK9 promotes hepatic lipogenesis and atherosclerosis development via apoE- and LDLR-mediated mechanisms.
Tavori H; Giunzioni I; Predazzi IM; Plubell D; Shivinsky A; Miles J; Devay RM; Liang H; Rashid S; Linton MF; Fazio S
Cardiovasc Res; 2016 May; 110(2):268-78. PubMed ID: 26980204
[TBL] [Abstract][Full Text] [Related]
17. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.
Linton MF; Hasty AH; Babaev VR; Fazio S
J Clin Invest; 1998 Apr; 101(8):1726-36. PubMed ID: 9541504
[TBL] [Abstract][Full Text] [Related]
18. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages.
Aiello RJ; Brees D; Bourassa PA; Royer L; Lindsey S; Coskran T; Haghpassand M; Francone OL
Arterioscler Thromb Vasc Biol; 2002 Apr; 22(4):630-7. PubMed ID: 11950702
[TBL] [Abstract][Full Text] [Related]
19. Hepatic expression of apolipoprotein E inhibits progression of atherosclerosis without reducing cholesterol levels in LDL receptor-deficient mice.
Tsukamoto K; Tangirala RK; Chun S; Usher D; Puré E; Rader DJ
Mol Ther; 2000 Feb; 1(2):189-94. PubMed ID: 10933930
[TBL] [Abstract][Full Text] [Related]
20. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis.
Christoffersen C; Pedersen TX; Gordts PL; Roebroek AJ; Dahlbäck B; Nielsen LB
Circ Res; 2010 May; 106(10):1624-34. PubMed ID: 20360257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
